Skip to main content
Adverio logo
Casper, Wyoming|Ecommerce Marketing
+173% Revenue & +414% Profit in 9 Months: How HemRid Broke a 17-Month Plateau and Reached #3 in OTC
HemRid·2024

+173% Revenue & +414% Profit in 9 Months: How HemRid Broke a 17-Month Plateau and Reached #3 in OTC

+173% in 9 months
Revenue Growth
+414% in 9 months
Profit Growth
#3 in OTC
Category Position
17 months
Plateau Duration (Before)
24
SKUs Governed
Amazon, DSP, Google
Platforms

HemRid had been stuck for 17 months. Revenue was flat, profit wasn't growing, and the brand was competing against entrenched pharma players with no room to throw money at the problem. After partnering with Adverio, HemRid grew revenue 173%, profit 414%, and earned the #3 position in its OTC category, trailing only two major pharmaceutical brands, all in nine months.

Challenge

Seventeen months of flatlined revenue is a system problem, not a lever problem. The existing operating model had hit its ceiling. Profit stagnation was limiting reinvestment capacity, which meant every dollar deployed had to produce measurable returns. The OTC category is dominated by pharma giants with deep pockets. Matching them on spend wasn't an option. The only path forward was a smarter structure.

Solution

Adverio deployed a four-part Market Leadership Engine. First, SKU governance: the 24-SKU catalog was treated as a portfolio, with budget allocated by contribution margin rather than volume. High-performing SKUs scaled aggressively, margin drivers were protected, and low-incrementality spend was cut. Second, Amazon PPC was restructured for non-branded expansion while DSP captured high-intent audiences across the full funnel. Third, Google was used not as a standalone channel but as a demand input layer, injecting incremental traffic into the Amazon ecosystem and reducing dependency on rising CPCs. Fourth, daily optimization loops compounded small gains across every layer of the account, with continuous pruning and rapid reinvestment into proven growth pockets.

Results

Revenue grew 173% in nine months, breaking the 17-month plateau. Profit surged 414%, unlocking reinvestment capacity the brand hadn't had before. HemRid earned the #3 category position in OTC, behind only two large pharmaceutical competitors. All 24 SKUs are now governed under a profit-first system, and the growth was structural, not a temporary spike.

Label: Breaking Through a 17-Month Plateau

When a brand is stuck for 17 months, the temptation is to spend more. More budget, more campaigns, more channels. That usually makes things worse. HemRid's problem wasn't a lack of activity. It was that the operating model had maxed out. Budget was spread across 24 SKUs without any real logic tying allocation to profit contribution. Adverio rebuilt the entire system from the SKU level up, governed spend by incrementality rather than volume, and layered in DSP and Google only after the Amazon foundation was producing clean returns. The result wasn't just growth. It was a category position that the brand now owns.

Project Details

Year

2024

Duration

9 months

Live ProjectView →